Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BFRI is expected to report earnings to fall 53.19% to -21 cents per share on August 11
Q2'23
Est.
$-0.22
Q1'25
Missed
by $0.28
Q4'24
Beat
by $0.02
Q1'23
Missed
by $0.20
Q4'22
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -46 cents, missing the estimate of -18 cents. With 58.85K shares outstanding, the current market capitalization sits at 9.77M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BFRI showed earnings on May 15, 2025. You can read more about the earnings report here.